Company news: Lighthouse Learning and Shire

Share this article:

The ACCME awarded provisional two-year accreditation to Lighthouse Learning, the educational content provider which develops and sells CME curricula without accepting commercial funding. In 2011, Lighthouse said, it conducted activities with other organizations serving as joint sponsor—Annenberg Center for Health Sciences at Eisenhower and Oakstone Medical Publishing/CMEinfo. The firm was started last year by a Harvard neurologist and two executives.

Shire received FDA approval for Firazyr to treat acute attacks from hereditary angioedema (HAE), a rare swelling disorder. The drug's self-injectable formulation may give it a marketing edge over HAE products Berinert, from CSL Behring, which is administered by IV infusion, and Kalbitor, from Dyax, which is injectable but must be given by a doctor. Cinryze, from ViroPharma, is self-administered by patients every three to four days to prevent HAE attacks. A fifth HAE drug, Rhucin (marketed as Ruconest in Europe), is in phase III trials and is being developed by Pharming NV.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.